Myocet Plus Endoxan for Older Patients With Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Cyclophosphamide|DRUG: Liposomal-encapsulated doxorubicin
Sponsor: Hellenic Oncology Research Group